Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions
Status:
Terminated
Trial end date:
2007-10-22
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, multicenter phase III trial to assess the efficacy of
early administration of zoledronate versus observation in delaying bone-related symptoms in
metastatic breast cancer patients.